<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02398474</url>
  </required_header>
  <id_info>
    <org_study_id>2014-003383-21</org_study_id>
    <nct_id>NCT02398474</nct_id>
  </id_info>
  <brief_title>Ultrasound TFP (Transversalis Fascia Plane) for Analgesia After Iliac Crest Bone Graft Harvest</brief_title>
  <acronym>TFP</acronym>
  <official_title>Intérêt du TFP (Transversalis Fascia Plane) Bloc échoguidé Pour l'analgésie du prélèvement Osseux de crête Iliaque</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <brief_summary>
    <textblock>
      Iliac crest bone graft harvest is associated with acute pain that can lead to chronic
      postoperative pain. Local anesthetic infiltration and regional anesthesia could be of
      interest to reduce opioid consumption during and after surgery, reduce hyperalgesia and the
      associated risk of chronic postoperative pain. In this surgery, local anesthetic infiltration
      of the iliac crest is associated with a pain reduction compare with placebo.

      Some studies have shown the benefit of a TAP (transversus abdominal block) for postoperative
      analgesia after iliac crest bone graft harvest. The TFP block (transversalis fascia plane
      block) has been recently described. Considering the nerves trajectories, the TFP block is
      probably anatomically the most appropriate block for analgesia after iliac crest bone graft
      harvest.

      The aim of this study is therefore to assess the benefit of an ultrasound TFP block for
      analgesia after iliac crest bone graft harvest compare with local anesthetic infiltration
      Design is prospective, randomized, double blind, controlled study
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine consumption 24 hours after the surgery</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Patients Scheduled for Iliac Crest Bone Graft Harvest During Upper or Lower Limb Surgery</condition>
  <arm_group>
    <arm_group_label>iliac crest bone graft with a TFP block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Regional anesthesia (RA) for the upper or lower limb depending on the surgery + general anesthesia (GA) + TFP block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local anesthetic infiltration of the surgical site.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RA for the upper or lower limb depending on the surgery + GA + ropivacaine infiltration of the iliac crest bone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TFP block ropivacaine</intervention_name>
    <arm_group_label>iliac crest bone graft with a TFP block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine infiltration of the iliac crest bone</intervention_name>
    <arm_group_label>local anesthetic infiltration of the surgical site.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Patients scheduled for iliac crest bone graft harvest during upper or lower limb
             surgery

        Exclusion Criteria:

          -  Allergy to ropivacaine, propofol, paracetamol, remifentanil, morphine, cisatracurium,
             ketoprofene, nefopam

          -  Weight &lt; 50 kg

          -  Pregnancy

          -  Severe psychiatric disorder

          -  Paraplegia or tetraplegia

          -  Spinal anesthesia

          -  Contra indication to ketoprofene: age ≥ 75 years, renal insufficiency (creatinine
             clearance &lt; 50 ml/min), active gastric ulcer, past of asthma with NSAID

          -  Contra indication to nefopam: severe cardiac insufficiency, glaucoma, prostate
             hypertrophy, epilepsy

          -  Contra indication to paracetamol: severe hepatic insufficiency

          -  Severe respiratory insufficiency

          -  Abnormal hemostasis or anticoagulant treatment

          -  Chronic use of morphine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beloeil Hélène</last_name>
      <phone>02 99 28 43 21</phone>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2015</study_first_submitted>
  <study_first_submitted_qc>March 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2015</study_first_posted>
  <last_update_submitted>July 19, 2017</last_update_submitted>
  <last_update_submitted_qc>July 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

